Is Johnson & Johnson a Good Stock to Buy?

Page 1 of 2

Johnson & Johnson (NYSE:JNJ) currently trades at 23 times trailing earnings, which we’d normally consider to be a bit high for a stable consumer health and healthcare company. Revenue was 7% higher in the third quarter of 2012 than in the same period in 2011. While earnings were down, that decrease was entirely due to higher research and development expenses; if we strip out an in-process R&D expense pretax income was actually up 4%, and there were increases in the normal R&D item as well. Of course, it’s possible that for whatever reason these increases in spending are permanent rather than that they are one-time items which will be reversed in the coming quarters, allowing the company to capitalize on its higher revenues merely on a delayed basis. In theory, however, Johnson & Johnson should not need to dedicate further revenue growth to research and development and as we can see from these results it would likely not have to increase other costs by much either.

FISHER ASSET MANAGEMENT

Yet even if we assume a modest increase in earnings we’re not sure that the company’s recent performance justifies its current valuation. Wall Street analyst expectations are for $5.49 per share in earnings for 2013, implying a forward P/E of only 13. That would be a more reasonable multiple for the company, though it of course depends on higher net income this year than last year. It should also be noted that Johnson & Johnson is something of a classic defensive stock, and it does have both a low beta (at 0.4) and a moderately high dividend yield (at 3.4%).

Johnson & Johnson was billionaire Ken Fisher’s Fisher Asset Management’s second largest single-stock holding by market value at the end of September, with a position of close to 11 million shares (find more of Fisher’s stock picks). It was also the top pick of Fairfax Financial Holdings; Fairfax is managed by Prem Watsa, who has been called “the Warren Buffett of Canada.” Research more of Watsa’s favorite stocks. George Soros was buying Johnson & Johnson during the third quarter as well (check out more stocks Soros was buying).

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

The 10 Most Peaceful Countries in the World

5 Big Reasons Communism Failed

The 15 Most Famous Carl Icahn Quotes

10 Scary Animals that are Actually Harmless

The 8 Most Famous Singer-Actors in Entertainment

The 10 Longest Wars of All Time

The 13 Worst Looking Foods that Taste Great

The 6 Most Gruesome Injuries Suffered During a Sports Match

The 20 Biggest Contracts in MLB History

The 7 Worst Blown Calls in Sports History

7 Free Ways to Advertise Your Business Online

The 18 Best R&B Songs of the 90’s

The 10 Most Dangerous States to be a Cop

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!